USANA Health Sciences, Inc. (NYSE:USNA) Director Myron W. Wentz sold 28,788 shares of the stock in a transaction dated Friday, September 15th. The stock was sold at an average price of $57.19, for a total value of $1,646,385.72. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink.

Shares of USANA Health Sciences, Inc. (USNA) traded down 0.61% during trading on Friday, hitting $57.00. The stock had a trading volume of 185,419 shares. The company has a market capitalization of $1.39 billion, a P/E ratio of 14.81 and a beta of 1.10. USANA Health Sciences, Inc. has a 1-year low of $52.55 and a 1-year high of $75.00. The firm has a 50-day moving average of $57.59 and a 200 day moving average of $60.18.

USANA Health Sciences (NYSE:USNA) last posted its earnings results on Tuesday, July 25th. The company reported $0.98 EPS for the quarter, missing the consensus estimate of $1.06 by ($0.08). The business had revenue of $257.10 million for the quarter, compared to the consensus estimate of $273.61 million. USANA Health Sciences had a return on equity of 28.93% and a net margin of 9.47%. The company’s revenue was down .5% on a year-over-year basis. During the same period in the previous year, the firm earned $2.07 earnings per share. Equities research analysts predict that USANA Health Sciences, Inc. will post $3.79 earnings per share for the current fiscal year.

USANA Health Sciences announced that its Board of Directors has initiated a share buyback program on Tuesday, July 25th that permits the company to repurchase $64.60 million in shares. This repurchase authorization permits the company to purchase up to 46% of its shares through open market purchases. Shares repurchase programs are often a sign that the company’s board believes its stock is undervalued.

ILLEGAL ACTIVITY NOTICE: “USANA Health Sciences, Inc. (USNA) Director Myron W. Wentz Sells 28,788 Shares” was posted by Daily Political and is owned by of Daily Political. If you are reading this news story on another site, it was stolen and reposted in violation of US and international copyright and trademark laws. The original version of this news story can be viewed at https://www.dailypolitical.com/2017/09/15/usana-health-sciences-inc-usna-director-myron-w-wentz-sells-28788-shares.html.

A number of hedge funds have recently modified their holdings of USNA. Janney Montgomery Scott LLC grew its position in USANA Health Sciences by 37.7% in the 1st quarter. Janney Montgomery Scott LLC now owns 6,619 shares of the company’s stock worth $381,000 after purchasing an additional 1,813 shares in the last quarter. Russell Investments Group Ltd. grew its position in USANA Health Sciences by 11.8% in the 1st quarter. Russell Investments Group Ltd. now owns 27,619 shares of the company’s stock worth $1,591,000 after purchasing an additional 2,926 shares in the last quarter. Wells Fargo & Company MN grew its position in USANA Health Sciences by 70.8% in the 1st quarter. Wells Fargo & Company MN now owns 31,480 shares of the company’s stock worth $1,814,000 after purchasing an additional 13,044 shares in the last quarter. First Trust Advisors LP grew its position in USANA Health Sciences by 104.3% in the 1st quarter. First Trust Advisors LP now owns 25,069 shares of the company’s stock worth $1,444,000 after purchasing an additional 12,800 shares in the last quarter. Finally, Karp Capital Management Corp bought a new stake in USANA Health Sciences in the 1st quarter worth about $595,000. 44.90% of the stock is owned by institutional investors and hedge funds.

A number of equities analysts have issued reports on the company. BidaskClub upgraded USANA Health Sciences from a “strong sell” rating to a “sell” rating in a report on Tuesday, August 22nd. Pivotal Research lowered their target price on USANA Health Sciences from $75.00 to $70.00 and set a “buy” rating for the company in a report on Wednesday, July 26th.

About USANA Health Sciences

USANA Health Sciences, Inc develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia.

Insider Buying and Selling by Quarter for USANA Health Sciences (NYSE:USNA)

Receive News & Ratings for USANA Health Sciences Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences Inc. and related companies with MarketBeat.com's FREE daily email newsletter.